• Search results for Covaxin
Image Title
What_the_FAQs_1

What the FAQ: How did Haffkine Institute get the Centre’s permission to manufacture Covaxin?

While states have been running out of vaccines, the Ventre gave their nod for Maharashtra to begin the manufacture of Covaxin locally

Published on 16th April 2021
covid_child

We may have COVID-19 vaccine for children by September: Director, National Institute of Virology 

The NIV director informed that apart from the Covaxin, Zyuds Cadila's vaccine trial for children is also underway

Published on 19th August 2021
vaccine-5873170_1920

Two-year-old gets vaccine jab in UP as part of Bharat Biotech's ongoing Covaxin trials

In May, the Drugs Controller General of India (DCGI) had granted permission to Bharat Biotech to commence phase 2-3 trials of Covaxin on children as young as two

Published on 24th June 2021

Study finds that majority of Indians experience mild or no side effects post COVID-19 vax

According to the study, 70 per cent of Indians after taking the first dose of Covishield and 64 per cent with Covaxin experienced no or mild side effects

Published on 25th August 2021
COVID-19-Vaccine-6-3

Students travelling to study abroad worried about visa cancellation over COVID vaccine shortage

Indian students who have received Covaxin or Russia's Sputnik V vaccine are being asked to inoculate again across several international institutes as these vaccines are yet to be approved by WHO

Published on 9th June 2021
covid_vaccine

Serum Institute of India gets Oxford-AstraZeneca vaccine purchase order from Centre 

The SII vaccine developed by Oxford-AstraZeneca was cleared for emergency use along with Bharat Biotech's indigenous "Covaxin" earlier this month

Published on 11th January 2021
coronavirus-collateral

Recruitment for clinical trial of Covaxin in 6-12 age group to start at AIIMS from June 15

The enrolment of children volunteers aged 12-18 years at the All India Institute of Medical Sciences (AIIMS) has been completed and they have been given the first dose of Covaxin

Published on 14th June 2021
vaccine

PM's move to get inoculated would instill confidence among people, remove hesitancy: AIIMS Chief

Guleria said that Sister P Niveda, from Puducherry who administered the Covaxin jab to the prime minister, was informed about her high-profile task only in the morning

Published on 1st March 2021
covaxin-1603676480

Plea in Delhi HC seeking stay on Phase II/III clinical trial of Covaxin in 2 to 18 age group. Here's why

Fresh application seeks to stay the operation of the order of DCGI till disposal of the ongoing petition in the interest of justice

Published on 3rd June 2021
Proper-storage-temperature-is-crucial-to-vaccine-potency

Phase 1 trial results show Covaxin has tolerable safety, enhanced immunity, finds Lancet study

Covaxin, which is now undergoing phase-3 trials, had raised concerns among experts over its emergency approval earlier this month by India's drug regulator

Published on 22nd January 2021
COVID-19-Vaccine-6-3

Mixing Covishield and Covaxin can yield better results against COVID, says ICMR's new study

The study was conducted on individuals in Uttar Pradesh who received Covishield as the first dose followed by inadvertent administration of Covaxin as the second dose at an interval of six weeks

Published on 8th August 2021
COVID-19-Vaccine-6-3

Indian government dismisses reports that Covaxin may hamper plans to travel abroad

Multiple reports had said that over 130 countries across the globe currently accept Serum Institute of India's Covishield vaccine to enter their country while Covaxin is accepted in only nine n

Published on 22nd May 2021
covid

India reports 62,258 new COVID cases. Steep rise in cases since March 16

As of date, 5.81 crore doses of corona vaccine have been administered in the country since the drive began on January 16 after approval for 'Covishield' and 'Covaxin

Published on 27th March 2021
Covishield

Govt has released full advance for Covishield vaccine to SII on April 28: Health Ministry

Additionally, 100 per cent advance of Rs 787.50 crore (after TDS Rs 772.50 crore) was released on April 28 to Bharat Biotech India Ltd (BBIL) for five crore Covaxin doses during May, June and July

Published on 3rd May 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Government asks Serum Institute, Bharat Biotech to lower the price of COVID-19 vaccines: Official sources

The Hyderabad-based Bharat Biotech has fixed the price of its COVID-19 vaccine, Covaxin, at Rs 600 per dose for state governments and at Rs 1,200 per dose for private hospitals

Published on 27th April 2021

Search results 1 - 15 of 127